On the other hand, high expression of UCHL1 was found to be inversely correlated with survival rate, in which UCHL1 deubiquitinated the epidermal growth factor receptor, thus suppressing ERα gene transcription, leading to resistance to anti-estrogen therapy in treating breast cancer [80]. Here, ESR1 is linked to breast carcinoma.